argenx
Aniruddha Mehta currently serves as the Director of Global Patient Safety BIS at argenx, a position held since April 2025. Prior to this role, Aniruddha held various positions at Blueprint Medicines, including Senior Manager and Manager in Drug Safety Systems from January 2022 to May 2025. Aniruddha's experience also includes working as a Safety Systems Analyst at Alkermes and a BI Architect at IQVIA. Previous roles include Lead Technology at Synechron and Technology Analyst at Infosys Limited, where Aniruddha contributed to OBIEE/OBIA and Informatica development. Aniruddha holds a Bachelor of Engineering degree in Electrical Engineering from UCE, Rajasthan Technical University, earned between 2005 and 2009, and completed secondary and higher secondary education at DAV Public School and Bhartee Vidhya Bhawan Sr Sec School, respectively.
This person is not in any teams
This person is not in any offices
argenx
32 followers
Argenx discovers, designs and develops innovative antibody therapeutics for its own pipeline of treatments for cancer and autoimmune diseases and for its partners. Harnessing our technology and know-how, we aim to meet the needs of patients by engineer...